Permitted Indications
Colistimethate sodium inhalation powder (Colobreathe®)
Only on the advice of a Cystic Fibrosis Specialist prior to continuation in Primary Care for:
- First line use for suppressive therapy of chronic pulmonary infection due to Pseudomonas aeruginosa in adults and children aged 6 years and older with cystic fibrosis.
Colistimethate sodium injection
Only on the advice of a Medical Microbiologist, Infection Specialist or Respiratory Specialist for:
- Patients with gram-negative infections resistant to other antibacterials.
- As a nebulised solution for suppressive therapy of chronic pulmonary infection due to Pseudomonas aeruginosa in children aged >1 month and adults with cystic fibrosis.